ICM
IDXX icon

Islay Capital Management’s Idexx Laboratories IDXX Stock Holding History

Islay Capital Management’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-40
Closed -$13K – 258
2022
Q3 		$13K Hold
40
– – 0.02% 198
2022
Q2 		$14K Hold
40
– – 0.01% 221
2022
Q1 		$22K Sell
40
-20
-33% -$10.5K 0.02% 217
2021
Q4 		$40K Hold
60
– – 0.03% 195
2021
Q3 		$37K Hold
60
– – 0.03% 210
2021
Q2 		$38K Hold
60
– – 0.03% 208
2021
Q1 		$29K Hold
60
– – 0.02% 199
2020
Q4 		$30K Hold
60
– – 0.03% 197
2020
Q3 		$24K Buy
+60
New +$22.2K 0.02% 204

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Islay Capital Management's IDXX Position: Q4 2022 in Review

Islay Capital Management sold out of Idexx Laboratories (IDXX) in Q4 2022, closing a stake of 40 shares — an estimated $13K sold.

Islay Capital Management first reported a position in IDXX in Q3 2020 and held it in 9 quarters. The position peaked at $40K in Q4 2021. 999 funds tracked by Wall St. Rank hold IDXX as of Q4 2022.

  • Islay Capital Management reported no remaining Idexx Laboratories position as of Q4 2022 after selling out during the quarter.
  • Islay Capital Management sold 40 Idexx Laboratories shares in Q4 2022, an estimated $13K.
  • Islay Capital Management first reported a position in Idexx Laboratories in Q3 2020 and held it in 9 quarters.
  • Islay Capital Management's Idexx Laboratories position peaked at $40K in Q4 2021.
  • 999 funds tracked by Wall St. Rank held Idexx Laboratories as of Q4 2022.

Based on Islay Capital Management's 13F filing for Q4 2022, filed 31 Jan 2023.